Embecta Corp.

Embecta Corp.

EMBC · Nasdaq

Embecta Corp. (EMBC) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Embecta Corp. in 2026. The next earnings report is expected on December 1, 2026.

Earnings calendar

Next earnings date

01 Dec 2026

In 103 days

EPS estimate

0.34

Revenue estimate

283.6M

Past earnings

07 Aug 2026
EPS actual
0.56 (+110.7%)
estimate 0.27
Revenue actual
271.7M (+6.7%)
estimate 254.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
05 May 2026
EPS actual
0.27 (-35.2%)
estimate 0.42
Revenue actual
221.8M (-5.9%)
estimate 235.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
05 Feb 2026
EPS actual
0.71 (+5.8%)
estimate 0.67
Revenue actual
261.2M (+1.2%)
estimate 258.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
25 Nov 2025
EPS actual
0.50 (+9.9%)
estimate 0.46
Revenue actual
263.3M (-0.9%)
estimate 265.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Embecta Corp. beat consensus estimates in its latest earnings report, with EPS of $0.56, 110.7% above expectations, and revenue of $271.7 million, 6.7% above estimates. In the prior quarter both EPS and revenue missed expectations.

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Frequency

Quarterly

Past dividends

Ex-dividend Payment Amount
28 May 2026 15 Jun 2026 0.01
27 Feb 2026 17 Mar 2026 —

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Sector
Healthcare
Industry
Drug manufacturers specialty generic
Country
United States
Exchange
Nasdaq
CEO
Devdatt Kurdikar
Employees
2,000
IPO date
22 Mar 2022
ISIN
US29082K1051
Website
embecta.com

Frequently asked questions

When does Embecta Corp. (EMBC) next report earnings?

Embecta Corp. (EMBC) is scheduled to report earnings on December 1, 2026.

What was Embecta Corp.'s most recent earnings date?

Embecta Corp. (EMBC) last reported earnings on August 7, 2026.

How often does Embecta Corp. pay dividends?

Based on historical data, Embecta Corp. (EMBC) pays dividends quarterly.

Where is Embecta Corp. stock listed?

Embecta Corp. (EMBC) is listed on Nasdaq.